Nifty

:

9039.25

Sensex

:

30672.59

-67.00 (-0.74%)
-260.31 (-0.84%)

Login

Nifty
Sensex

:
:

9039.25
30672.59

-67.00 (-0.74%)
-260.31 (-0.84%)

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

62/99

BSE: 500288 | NSE: MOREPENLAB

Watchlist

NSE BSE

15.55

22-May-2020

Open
High
Low
Previous Close

15.90
15.95
15.50
15.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

357259
55.98
23.95
7.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

699.48
21.16
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

679.21
N/A
2.55

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.75
13.92
8.88

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.23
6.96
1.93

PAT CAGR (%)

10 Years
5 Years
3 Years

-
68.25
6.88

P:E (Median)

8 Years
5 Years
3 Years

28.12
46.21
32.30

P:BV (Average)

8 Years
5 Years
3 Years

3.53
4.86
4.32

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.79
16.24
14.53

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var%
Net Sales 213.49 198.32 7.65% 199.88 162.01 23.38% 189.47 150.84 25.61% 206.07 158.22 30.24%
Expenses 199.71 181.56 10.00% 184.99 145.55 27.10% 170.02 139.10 22.23% 186.01 143.67 29.47%
EBITDA 13.77 16.77 -17.89% 14.90 16.46 -9.48% 19.44 11.74 65.59% 20.06 14.55 37.87%
EBIDTM 6.45% 8.45% 7.45% 10.16% 10.26% 7.78% 9.74% 9.20%
Other Income 4.60 2.43 89.30% 2.81 0.13 2,061.54% 0.28 0.08 250.00% 1.03 0.12 758.33%
Interest 0.54 0.42 28.57% 0.39 0.31 25.81% 0.42 0.43 -2.33% 0.92 0.79 16.46%
Depreciation 7.93 9.04 -12.28% 7.63 9.18 -16.88% 10.90 8.83 23.44% 10.95 9.77 12.08%
PBT 9.90 9.74 1.64% 9.69 7.10 36.48% 8.41 2.55 229.80% 9.22 4.11 124.33%
Tax 0.00 0.00 0 5.15 -0.19 - 0.00 0.19 -100.00% 0.00 0.00 0
PAT 9.90 9.74 1.64% 4.54 7.29 -37.72% 8.41 2.36 256.36% 9.22 4.11 124.33%
PATM 4.64% 4.91% 2.27% 4.50% 4.44% 1.57% 4.47% 2.60%
EPS 0.22 0.22 0.00% 0.10 0.16 -37.50% 0.19 0.05 280.00% 0.21 0.09 133.33%

Description Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var%
Net Sales 230.06 212.16 8.44% 213.43 173.94 22.70% 202.98 163.73 23.97% 218.72 171.46 27.56%
Expenses 214.75 195.32 9.95% 198.37 157.17 26.21% 183.65 151.55 21.18% 196.97 153.61 28.23%
EBITDA 15.30 16.83 -9.09% 15.06 16.76 -10.14% 19.33 12.18 58.70% 21.75 17.85 21.85%
EBIDTM 6.65% 7.93% 7.05% 9.64% 9.52% 7.44% 9.94% 10.41%
Other Income 4.60 2.43 89.30% 2.81 0.13 2,061.54% 0.28 0.08 250.00% 1.03 0.30 243.33%
Interest 0.54 0.43 25.58% 0.39 0.32 21.88% 0.43 0.44 -2.27% 0.93 0.81 14.81%
Depreciation 8.54 9.80 -12.86% 8.24 9.79 -15.83% 11.50 9.16 25.55% 11.15 10.39 7.31%
PBT 10.82 9.04 19.69% 9.24 6.79 36.08% 7.68 2.65 189.81% 10.70 6.96 53.74%
Tax 0.01 0.13 -92.31% 5.15 -0.19 - 0.02 0.19 -89.47% 0.21 -0.03 -
PAT 10.82 8.91 21.44% 4.09 6.97 -41.32% 7.66 2.46 211.38% 10.49 6.99 50.07%
PATM 4.70% 4.20% 1.92% 4.01% 3.77% 1.50% 4.80% 4.08%
EPS 0.24 0.20 20.00% 0.09 0.16 -43.75% 0.17 0.05 240.00% 0.23 0.15 53.33%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 808.91 717.24 560.83 547.51 452.46 370.26 335.97 303.35 269.50 216.31 195.83 Net Sales Growth 20.84% 27.89% 2.43% 21.01% 22.20% 10.21% 10.75% 12.56% 24.59% 10.46% Cost Of Goods Sold 536.78 448.98 335.30 328.24 273.04 223.63 194.39 185.79 172.43 140.48 123.64 Gross Profit 272.13 268.26 225.52 219.27 179.42 146.64 141.58 117.56 97.07 75.83 72.20 GP Margin 33.64% 37.40% 40.21% 40.05% 39.65% 39.60% 42.14% 38.75% 36.02% 35.06% 36.87% Total Expenditure 740.73 652.22 500.56 487.02 388.26 323.68 290.16 274.37 251.87 209.07 182.13 Power & Fuel Cost - 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 6.01 % Of Sales - 1.84% 1.98% 1.80% 1.69% 2.00% 2.51% 2.95% 3.64% 3.56% 3.07% Employee Cost - 84.74 68.22 60.79 51.67 43.52 39.16 34.47 32.12 26.79 21.15 % Of Sales - 11.81% 12.16% 11.10% 11.42% 11.75% 11.66% 11.36% 11.92% 12.39% 10.80% Manufacturing Exp. - 31.27 16.21 15.05 13.33 12.63 12.23 11.33 11.34 11.40 9.32 % Of Sales - 4.36% 2.89% 2.75% 2.95% 3.41% 3.64% 3.73% 4.21% 5.27% 4.76% General & Admin Exp. - 31.21 24.35 21.53 15.34 13.77 14.60 11.43 12.18 10.06 11.03 % Of Sales - 4.35% 4.34% 3.93% 3.39% 3.72% 4.35% 3.77% 4.52% 4.65% 5.63% Selling & Distn. Exp. - 31.72 29.13 29.04 19.87 16.06 15.11 15.48 10.51 8.27 8.66 % Of Sales - 4.42% 5.19% 5.30% 4.39% 4.34% 4.50% 5.10% 3.90% 3.82% 4.42% Miscellaneous Exp. - 11.11 16.26 22.53 7.38 6.66 6.25 6.91 3.47 4.38 8.66 % Of Sales - 1.55% 2.90% 4.11% 1.63% 1.80% 1.86% 2.28% 1.29% 2.02% 1.18% EBITDA 68.17 65.02 60.27 60.49 64.20 46.58 45.81 28.98 17.63 7.24 13.70 EBITDA Margin 8.43% 9.07% 10.75% 11.05% 14.19% 12.58% 13.64% 9.55% 6.54% 3.35% 7.00% Other Income 8.72 3.67 3.54 3.72 1.17 1.36 0.79 2.62 1.02 1.04 0.33 Interest 2.27 2.07 4.29 7.47 10.41 8.63 9.89 11.61 7.96 6.23 4.00 Depreciation 37.41 38.01 33.40 33.56 34.92 38.59 45.77 45.74 46.89 45.78 45.63 PBT 37.22 28.61 26.12 23.17 20.04 0.72 -9.06 -25.75 -36.20 -43.73 -35.60 Tax 5.15 0.00 0.00 0.00 -0.14 0.14 0.00 0.00 0.00 -0.75 0.00 Tax Rate 13.84% 0.00% 0.00% 0.00% -0.90% 19.44% 0.00% 0.00% 0.00% 1.72% 0.00% PAT 32.07 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 -1.74 PAT before Minority Interest 32.07 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 -1.74 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.96% 3.99% 4.66% 4.23% 3.49% 0.16% -1.83% -7.47% -8.96% -19.87% -0.89% PAT Growth 36.47% 9.53% 12.73% 46.83% 2,620.69% - - - - - Unadjusted EPS 0.72 0.64 0.58 0.52 0.35 0.00 -0.15 -0.49 -0.55 -0.96 -0.04

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 865.19 768.54 606.51 595.47 485.08 400.64 366.85 325.92 289.34 228.30 211.86 Net Sales Growth 19.95% 26.72% 1.85% 22.76% 21.08% 9.21% 12.56% 12.64% 26.74% 7.76% Cost Of Goods Sold 570.89 479.12 361.28 358.35 293.33 238.62 209.04 193.53 178.07 142.68 127.05 Gross Profit 294.30 289.42 245.23 237.12 191.76 162.02 157.81 132.39 111.27 85.62 84.80 GP Margin 34.02% 37.66% 40.43% 39.82% 39.53% 40.44% 43.02% 40.62% 38.46% 37.50% 40.03% Total Expenditure 793.74 701.02 541.78 534.09 423.52 352.41 317.95 294.97 270.11 222.53 200.23 Power & Fuel Cost - 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 6.01 % Of Sales - 1.71% 1.83% 1.65% 1.57% 1.85% 2.30% 2.75% 3.39% 3.37% 2.84% Employee Cost - 95.36 76.53 69.69 58.29 48.79 45.08 39.17 36.05 30.52 23.48 % Of Sales - 12.41% 12.62% 11.70% 12.02% 12.18% 12.29% 12.02% 12.46% 13.37% 11.08% Manufacturing Exp. - 31.28 16.21 22.36 13.33 12.68 12.23 11.33 10.20 11.40 9.19 % Of Sales - 4.07% 2.67% 3.76% 2.75% 3.16% 3.33% 3.48% 3.53% 4.99% 4.34% General & Admin Exp. - 36.14 28.52 18.11 18.14 15.89 16.62 13.86 14.37 12.72 13.24 % Of Sales - 4.70% 4.70% 3.04% 3.74% 3.97% 4.53% 4.25% 4.97% 5.57% 6.25% Selling & Distn. Exp. - 32.73 30.04 25.79 23.45 21.40 19.55 20.40 15.85 11.26 18.13 % Of Sales - 4.26% 4.95% 4.33% 4.83% 5.34% 5.33% 6.26% 5.48% 4.93% 8.56% Miscellaneous Exp. - 13.20 18.11 29.95 9.35 7.61 7.01 7.72 5.75 6.26 18.13 % Of Sales - 1.72% 2.99% 5.03% 1.93% 1.90% 1.91% 2.37% 1.99% 2.74% 1.47% EBITDA 71.44 67.52 64.73 61.38 61.56 48.23 48.90 30.95 19.23 5.77 11.63 EBITDA Margin 8.26% 8.79% 10.67% 10.31% 12.69% 12.04% 13.33% 9.50% 6.65% 2.53% 5.49% Other Income 8.72 3.67 3.72 3.72 1.20 1.37 1.22 2.87 1.18 1.04 0.33 Interest 2.29 2.11 4.36 7.56 10.50 8.66 9.92 11.63 7.96 6.27 4.03 Depreciation 39.43 39.90 34.32 33.90 35.20 38.67 45.84 45.80 48.06 48.16 48.02 PBT 38.44 29.18 29.77 23.63 17.06 2.28 -5.64 -23.61 -35.61 -47.62 -40.10 Tax 5.39 0.34 0.00 0.00 -0.13 0.14 0.01 -0.01 0.06 -0.69 0.03 Tax Rate 14.02% 1.17% 0.00% 0.00% -1.03% 6.14% -0.36% 0.05% -0.25% 1.45% -0.48% PAT 33.06 28.85 29.59 23.63 12.80 2.14 -2.77 -20.52 -23.65 -46.93 -6.22 PAT before Minority Interest 33.06 28.84 29.77 23.63 12.80 2.14 -2.75 -20.52 -23.63 -46.93 -6.27 Minority Interest 0.00 0.01 -0.18 0.00 0.00 0.00 -0.02 0.00 -0.02 0.00 0.05 PAT Margin 3.82% 3.75% 4.88% 3.97% 2.64% 0.53% -0.76% -6.30% -8.17% -20.56% -2.94% PAT Growth 30.52% -2.50% 25.22% 84.61% 498.13% - - - - - Unadjusted EPS 0.73 0.64 0.66 0.53 0.28 0.04 -0.07 -0.45 -0.54 -1.04 -0.15

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 277.46 250.56 224.34 328.85 313.08 324.26 330.42 353.09 377.26 420.24 Share Capital 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 187.50 160.60 134.38 119.24 103.47 114.65 120.81 143.48 167.65 210.63 Non-Current Liabilities 21.11 17.87 15.28 55.22 72.69 84.05 103.36 121.93 134.86 139.74 Secured Loans 1.79 2.70 0.94 42.74 62.22 74.65 94.49 98.85 114.37 128.45 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 11.29 Long Term Provisions 17.85 13.45 12.69 10.71 8.71 7.35 6.78 5.60 3.75 0.00 Current Liabilities 320.82 322.21 308.19 150.78 114.44 99.58 107.72 107.69 103.74 86.21 Trade Payables 157.08 164.89 116.20 107.48 78.55 66.75 54.90 63.59 57.32 72.02 Other Current Liabilities 153.61 156.05 190.70 39.14 32.82 30.91 52.14 43.20 44.68 11.14 Short Term Borrowings 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 0.00 Short Term Provisions 1.14 1.26 1.29 4.16 0.84 0.73 0.68 0.90 1.74 3.06 Total Liabilities 619.39 590.64 547.81 534.85 500.21 507.89 541.50 582.71 615.86 646.19 Net Block 152.59 182.10 191.29 216.36 243.93 289.47 330.91 373.57 416.58 458.39 Gross Block 777.14 890.30 922.26 914.18 907.16 902.43 898.34 895.47 896.07 893.66 Accumulated Depreciation 624.55 708.20 730.96 697.82 663.23 612.96 567.43 521.90 479.49 435.27 Non Current Assets 336.06 363.54 369.25 387.98 395.80 415.92 454.30 496.93 539.79 580.30 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 117.69 117.69 117.69 117.69 117.94 117.94 121.81 121.81 121.91 121.91 Long Term Loans & Adv. 65.49 63.47 59.41 53.92 33.93 8.51 1.58 1.55 1.30 0.00 Other Non Current Assets 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 283.33 227.11 178.56 146.88 104.41 91.97 87.20 85.78 76.07 64.47 Current Investments 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 90.84 73.94 62.50 40.82 35.36 32.91 36.75 38.01 33.61 30.47 Sundry Debtors 121.96 110.22 83.10 80.35 48.45 40.09 36.59 33.13 27.73 20.57 Cash & Bank 31.98 5.70 6.75 3.63 8.60 8.07 4.72 3.96 2.34 0.82 Other Current Assets 38.52 5.49 4.55 5.81 12.00 10.90 9.14 10.68 12.39 12.62 Short Term Loans & Adv. 30.80 31.53 21.67 16.27 8.89 7.94 6.56 9.00 9.61 10.58 Net Current Assets -37.49 -95.10 -129.63 -3.91 -10.03 -7.61 -20.52 -21.91 -27.67 -21.74 Total Assets 619.39 590.65 547.81 534.86 500.21 507.89 541.50 582.71 615.86 646.19

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 253.09 225.94 196.26 300.28 287.48 297.11 299.88 320.40 344.05 390.99 Share Capital 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 163.13 135.98 106.30 90.67 77.87 87.50 90.27 110.79 134.44 181.38 Non-Current Liabilities 23.38 20.20 17.80 57.47 74.00 84.65 103.91 122.05 135.01 139.74 Secured Loans 1.83 2.95 1.38 43.41 62.27 74.78 94.65 98.85 114.37 128.45 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 11.29 Long Term Provisions 19.01 14.42 13.59 11.34 9.22 7.82 7.17 5.73 3.90 0.00 Current Liabilities 339.17 340.12 324.86 166.56 127.92 108.14 102.73 104.95 102.78 85.24 Trade Payables 168.15 174.88 124.88 115.33 84.96 68.60 56.81 64.98 59.79 82.18 Other Current Liabilities 160.64 163.90 198.65 47.04 39.87 37.58 45.22 38.96 41.11 0.00 Short Term Borrowings 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 0.00 Short Term Provisions 1.39 1.33 1.33 4.19 0.86 0.77 0.70 1.01 1.88 3.06 Total Liabilities 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40 615.53 Net Block 236.21 264.29 271.80 296.72 322.48 368.08 409.46 451.86 496.02 540.18 Gross Block 887.76 997.60 1,026.96 1,018.43 1,009.35 1,004.61 1,000.44 997.38 997.96 995.54 Accumulated Depreciation 651.55 733.31 755.15 721.72 686.87 636.53 590.98 545.52 501.94 455.35 Non Current Assets 315.71 342.37 346.34 366.53 374.42 393.18 415.00 457.37 501.38 544.15 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 3.87 3.87 3.97 3.97 Long Term Loans & Adv. 79.22 77.81 73.69 69.82 51.94 25.10 1.67 1.64 1.39 0.00 Other Non Current Assets 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 299.47 243.44 191.95 157.15 114.58 96.32 91.09 89.61 80.02 69.96 Current Investments 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 94.20 76.89 64.66 42.14 37.11 33.30 37.05 38.66 34.70 31.68 Sundry Debtors 133.75 121.85 92.95 87.94 56.14 42.67 39.11 35.15 29.64 23.83 Cash & Bank 32.21 5.95 7.59 4.36 8.85 9.11 5.53 4.51 2.58 1.10 Other Current Assets 39.29 5.62 4.71 5.94 12.48 11.24 9.40 11.29 13.10 13.34 Short Term Loans & Adv. 31.43 32.92 22.03 16.77 9.34 8.23 6.23 9.60 10.30 11.19 Net Current Assets -39.70 -96.68 -132.92 -9.41 -13.34 -11.82 -11.64 -15.34 -22.76 -15.28 Total Assets 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40 615.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 14.58 61.25 49.24 50.01 50.74 33.19 33.46 26.77 9.67 6.62 PBT 28.61 26.12 22.55 20.04 0.72 -9.06 -25.75 -36.20 -43.73 -35.60 Adjustment 38.36 37.86 40.92 45.32 47.22 55.66 56.73 54.84 52.00 49.20 Changes in Working Capital -52.40 -2.72 -14.23 -11.09 2.94 -16.31 -0.60 -3.91 0.65 -6.60 Cash after chg. in Working capital 14.58 61.25 49.24 54.27 50.88 30.29 30.38 14.73 8.92 7.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.14 -0.14 0.00 0.00 0.00 0.75 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -4.40 0.00 2.90 3.08 12.04 0.00 -0.38 Cash From Investing Activity -10.34 -24.28 -14.67 -27.08 -30.22 -0.65 -2.51 -3.34 -3.85 -4.37 Net Fixed Assets 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 -4.29 Net Investments 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 0.00 Others -123.70 -56.02 -6.59 -20.31 -25.49 -0.43 0.36 -4.04 -1.44 -0.08 Cash from Financing Activity -0.35 -37.67 -31.29 -27.89 -19.99 -29.19 -30.19 -21.81 -4.30 -5.72 Net Cash Inflow / Outflow 3.89 -0.69 3.29 -4.97 0.53 3.35 0.76 1.62 1.52 -3.48 Opening Cash & Equivalents 5.47 6.16 2.87 8.60 8.07 4.72 3.96 2.34 0.82 4.30 Closing Cash & Equivalent 9.36 5.47 6.16 3.63 8.60 8.07 4.72 3.96 2.34 0.82

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 17.37 63.41 40.73 50.07 50.70 33.52 33.64 27.11 11.13 6.67 PBT 29.18 29.77 23.04 17.06 2.28 -5.64 -23.60 -35.61 -47.62 -40.10 Adjustment 40.33 38.64 41.40 45.69 47.32 55.76 56.80 55.99 54.44 51.68 Changes in Working Capital -51.79 -5.00 -23.72 -8.41 1.23 -19.50 -2.64 -5.25 3.63 -4.50 Cash after chg. in Working capital 17.71 63.41 40.73 54.34 50.83 30.62 30.56 15.13 10.45 7.08 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.34 0.00 0.00 0.13 -0.13 0.01 0.01 -0.06 0.68 -0.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -4.40 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -13.05 -26.93 -13.60 -27.30 -31.65 -0.80 -2.83 -3.35 -4.05 -4.43 Net Fixed Assets 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 -4.29 Net Investments 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 0.00 Others -126.41 -58.67 -5.52 -20.53 -26.92 -0.58 0.04 -4.05 -1.64 -0.14 Cash from Financing Activity -0.44 -37.77 -23.72 -27.26 -19.31 -29.14 -29.79 -21.83 -5.60 -5.72 Net Cash Inflow / Outflow 3.88 -1.29 3.40 -4.49 -0.26 3.58 1.02 1.93 1.48 -3.48 Opening Cash & Equivalents 5.72 7.00 3.60 8.85 9.11 5.53 4.51 2.58 1.10 4.59 Closing Cash & Equivalent 9.60 5.72 7.00 4.36 8.85 9.11 5.53 4.51 2.58 1.10

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 6.17 5.57 4.99 4.65 4.30 4.55 4.69 5.19 5.73 6.65 ROA 4.73% 4.59% 4.28% 3.05% 0.12% -1.17% -4.03% -4.03% -6.81% -0.26% ROE 10.84% 11.00% 10.69% 7.84% 0.29% -2.97% -10.21% -9.84% -15.44% -0.71% ROCE 7.74% 9.26% 9.17% 6.60% 2.32% 0.87% -2.42% -3.29% -7.02% 0.39% Fixed Asset Turnover 0.86 0.62 0.60 0.51 0.42 0.38 0.34 0.31 0.25 0.22 Receivable days 59.08 62.91 54.48 50.93 42.76 41.07 41.14 40.65 40.17 36.43 Inventory Days 41.93 44.40 34.44 30.13 32.97 37.31 44.11 47.84 53.30 48.30 Payable days 88.97 104.24 84.35 83.75 77.64 70.84 71.22 76.97 97.16 117.57 Cash Conversion Cycle 12.04 3.07 4.58 -2.69 -1.90 7.54 14.02 11.52 -3.69 -32.84 Total Debt/Equity 0.47 0.53 0.22 0.20 0.26 0.27 0.34 0.34 0.35 0.33 Interest Cover 14.82 7.08 4.10 2.50 1.08 0.38 -0.95 -2.04 -6.02 0.57

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 5.63 5.02 4.36 4.02 3.73 3.95 4.01 4.46 4.99 6.00 ROA 4.80% 5.30% 4.45% 2.53% 0.44% -0.55% -3.90% -4.19% -7.84% -0.99% ROE 12.04% 14.10% 12.54% 7.35% 1.24% -1.54% -10.77% -11.12% -18.99% -2.86% ROCE 12.38% 14.05% 10.18% 6.29% 2.90% 1.80% -2.09% -3.40% -8.22% -0.40% Fixed Asset Turnover 0.82 0.60 0.58 0.49 0.41 0.37 0.33 0.29 0.23 0.21 Receivable days 60.70 64.63 55.44 53.22 44.17 40.16 40.83 40.35 42.17 38.81 Inventory Days 40.63 42.59 32.73 29.27 31.48 34.55 41.63 45.68 52.36 46.50 Payable days 88.85 103.38 82.97 83.88 76.01 67.69 69.30 75.59 101.91 124.72 Cash Conversion Cycle 12.48 3.85 5.20 -1.39 -0.36 7.02 13.16 10.44 -7.39 -39.41 Total Debt/Equity 0.05 0.06 0.25 0.22 0.28 0.30 0.37 0.38 0.39 0.36 Interest Cover 14.83 7.83 4.13 2.21 1.26 0.72 -0.77 -1.96 -6.59 -0.55

Top Investors:

pinfold overseas limited

ferry holdings limited

life insurance corporation of india

damodar prasad agarwal

morepen laboratories ltd

Annual Reports:

News Update:

Morepen Laboratories gets ISO-13485 certification for Baddi medical devices manufacturing facility
30th Apr 2020, 11:04 AM

The certification has been awarded for the manufacturing, distribution and after sales service of all point-of-care diagnostic medical devices and their accessories
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback